VersaFoam Logo   Home Site Map Terms of Use Privacy Stiefel Laboratories Contact Us  
What is VersaFoam?
How does VersaFoam work?
VersaFoam Formulations
VersaFoam-HF
VersaFoam-EF
VersaFoam-AF
 
References:
1 Gottlieb AB, Odom Ford R, Spellman MC. The Efficacy and Tolerability of Clobetasol Propionate Foam 0.05% in the Treatment of Mild to Moderate Plaque-type Psoriasis of Nonscalp Regions. J Cut Med Surgery: 2003:7:185-192.
 
VERSAFOAM-HF™: The Original Formulation
VERSAFOAM Hydroethanolic Formulation (HF) is neither hydrating nor drying. It dissolves rapidly at skin temperature (90°F-95°F) and leaves minimal residue on the skin.
  • Easy to apply, leaving the skin feeling clean and smooth
  • Can be applied to both hair-bearing and non–hair-bearing areas, as well as the scalp
  • Patient-preferred; nonstaining, nondripping
  • Faster, greater penetration of active ingredients than other formulations
  • Complementary to other dermatological products
  • Cosmetic elegance: disappears into skin quickly
  • Preservative-free, paraben-free
  • Patented hydroethanolic formulations
Stiefel Products Formulated with VERSAFOAM-HF
Olux logo
OLUX®delivers the super-potent topical corticosteroid clobetasol propionate in the VERSAFOAM-HF™ vehicle. OLUX is indicated for short-term topical treatment of the inflammatory and pruritic manifestations of moderate to severe corticosteroid-responsive dermatoses of the scalp, and for short-term topical treatment of mild to moderate plaque-type psoriasis of non-scalp regions excluding the face and intertriginous areas.

Treatment with OLUX beyond two consecutive weeks is not recommended and the total dosage should not exceed 50 g per week because of the potential for the drug to suppress the hypothalamic-pituitary-adrenal (HPA) axis.

Link to Package Insert
Luxiq logo
LUXÍQ® delivers the mid-potency topical corticosteroid betamethasone valerate in the VERSAFOAM-HF™ vehicle. LUXÍQ is indicated for topical application in the treatment of the inflammatory and pruritic anifestations of corticosteroid-responsive dermatoses of the scalp.

Systemic absorption of topical corticosteroids has caused reversible hypothalamic-pituitary-adrenal (HPA) suppression with potential for glucocorticosteroid insufficiency after withdrawal of treatment.

Link to Package Insert
Evoclin logo
EVOCLIN® delivers the topical antibiotic clindamycin phosphate in the VERSAFOAM-HF™ vehicle. EVOCLIN is indicated for topical application in the treatment of acne vulgaris.

The most common adverse events in clinical trials were headache and application-site reactions including burning, itching, and dryness.

Link to Package Insert
Extina
EXTINA® Foam is the first and only ketoconazole foam for the treatment of seborrheic dermatitis. EXTINA Foam is a unique formulation of ketoconazole delivered in the VERSAFOAM-HF™ vehicle. EXTINA Foam is indicated for the topical treatment of seborrheic dermatitis in immunocompetent patients aged 12 years and older.

EXTINA® Foam may result in contact sensitization, including photoallergenicity.

Link to Package Insert
Other products
Mipharm S.p.A. Products
Men's Rogaine® Foam